Literature DB >> 33010004

AIP variant causing familial prolactinoma.

David M Carty1, Rachael Harte2, Russell S Drummond2, Rebecca Ward3, Kesson Magid4, David Collier4, Martina Owens5, Márta Korbonits4.   

Abstract

Pathogenic variants in the aryl hydrocarbon receptor-interacting protein (AIP) gene are increasingly recognised as a cause of familial isolated pituitary adenoma. AIP-associated tumours are most commonly growth hormone (GH) producing. In our cohort of 175 AIP mutation positive patients representing 93 kindreds, 139 (79%) have GH excess, 19 have prolactinoma (17 familial and 2 sporadic cases) and out of the 17 clinically non-functioning tumours 4 were subsequently operated and found to be GH or GH & prolactin immunopositive adenoma. Here we report a family with an AIP variant, in which multiple family members are affected by prolactinoma, but none with GH excess. To our knowledge this is the first reported family with an AIP pathogenic variant to be affected solely by prolactinoma. These data suggest that prolactinoma families represent a small subset of AIP mutation positive kindreds, and similar to young-onset sporadic prolactinomas, AIP screening would be indicated.

Entities:  

Keywords:  AIP mutation; Familial; Pituitary; Prolactinoma

Mesh:

Year:  2020        PMID: 33010004      PMCID: PMC7864850          DOI: 10.1007/s11102-020-01085-5

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  11 in total

1.  Clinical characterization of familial isolated pituitary adenomas.

Authors:  A F Daly; M-L Jaffrain-Rea; A Ciccarelli; H Valdes-Socin; V Rohmer; G Tamburrano; C Borson-Chazot; B Estour; E Ciccarelli; T Brue; P Ferolla; P Emy; A Colao; E De Menis; P Lecomte; F Penfornis; B Delemer; J Bertherat; J L Wémeau; W De Herder; F Archambeaud; A Stevenaert; A Calender; A Murat; F Cavagnini; A Beckers
Journal:  J Clin Endocrinol Metab       Date:  2006-06-20       Impact factor: 5.958

2.  AIP mutation in pituitary adenomas in the 18th century and today.

Authors:  Harvinder S Chahal; Karen Stals; Martina Unterländer; David J Balding; Mark G Thomas; Ajith V Kumar; G Michael Besser; A Brew Atkinson; Patrick J Morrison; Trevor A Howlett; Miles J Levy; Steve M Orme; Scott A Akker; Richard L Abel; Ashley B Grossman; Joachim Burger; Sian Ellard; Márta Korbonits
Journal:  N Engl J Med       Date:  2011-01-06       Impact factor: 91.245

3.  Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study.

Authors:  Adrian F Daly; Maria A Tichomirowa; Patrick Petrossians; Elina Heliövaara; Marie-Lise Jaffrain-Rea; Anne Barlier; Luciana A Naves; Tapani Ebeling; Auli Karhu; Antti Raappana; Laure Cazabat; Ernesto De Menis; Carmen Fajardo Montañana; Gerald Raverot; Robert J Weil; Timo Sane; Dominique Maiter; Sebastian Neggers; Maria Yaneva; Antoine Tabarin; Elisa Verrua; Eija Eloranta; Arnaud Murat; Outi Vierimaa; Pasi I Salmela; Philippe Emy; Rodrigo A Toledo; Maria Isabel Sabaté; Chiara Villa; Marc Popelier; Roberto Salvatori; Juliet Jennings; Angel Ferrandez Longás; José Ignacio Labarta Aizpún; Marianthi Georgitsi; Ralf Paschke; Cristina Ronchi; Matti Valimaki; Carola Saloranta; Wouter De Herder; Renato Cozzi; Mirtha Guitelman; Flavia Magri; Maria Stefania Lagonigro; Georges Halaby; Vinciane Corman; Marie-Thérèse Hagelstein; Jean-François Vanbellinghen; Gustavo Barcelos Barra; Anne-Paule Gimenez-Roqueplo; Fergus J Cameron; Françoise Borson-Chazot; Ian Holdaway; Sergio P A Toledo; Günter K Stalla; Anna Spada; Sabina Zacharieva; Jerome Bertherat; Thierry Brue; Vincent Bours; Philippe Chanson; Lauri A Aaltonen; Albert Beckers
Journal:  J Clin Endocrinol Metab       Date:  2010-08-04       Impact factor: 5.958

4.  Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.

Authors:  Thomas Cuny; Morgane Pertuit; Mona Sahnoun-Fathallah; Adrian Daly; Gianluca Occhi; Marie Françoise Odou; Antoine Tabarin; Marie Laure Nunes; Brigitte Delemer; Vincent Rohmer; Rachel Desailloud; Véronique Kerlan; Olivier Chabre; Jean-Louis Sadoul; Muriel Cogne; Philippe Caron; Christine Cortet-Rudelli; Anne Lienhardt; Isabelle Raingeard; Anne-Marie Guedj; Thierry Brue; Albert Beckers; Georges Weryha; Alain Enjalbert; Anne Barlier
Journal:  Eur J Endocrinol       Date:  2013-03-15       Impact factor: 6.664

5.  The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.

Authors:  Chrysanthia A Leontiou; Maria Gueorguiev; Jacqueline van der Spuy; Richard Quinton; Francesca Lolli; Sevda Hassan; Harvinder S Chahal; Susana C Igreja; Suzanne Jordan; Janice Rowe; Marie Stolbrink; Helen C Christian; Jessica Wray; David Bishop-Bailey; Dan M Berney; John A H Wass; Vera Popovic; Antônio Ribeiro-Oliveira; Monica R Gadelha; John P Monson; Scott A Akker; Julian R E Davis; Richard N Clayton; Katsuhiko Yoshimoto; Takeo Iwata; Akira Matsuno; Kuniki Eguchi; Mâdâlina Musat; Daniel Flanagan; Gordon Peters; Graeme B Bolger; J Paul Chapple; Lawrence A Frohman; Ashley B Grossman; Márta Korbonits
Journal:  J Clin Endocrinol Metab       Date:  2008-04-01       Impact factor: 5.958

6.  Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.

Authors:  Fred Williams; Steven Hunter; Lisa Bradley; Harvinder S Chahal; Helen L Storr; Scott A Akker; Ajith V Kumar; Stephen M Orme; Jane Evanson; Noina Abid; Patrick J Morrison; Márta Korbonits; A Brew Atkinson
Journal:  J Clin Endocrinol Metab       Date:  2013-01-01       Impact factor: 5.958

7.  Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.

Authors:  Laura C Hernández-Ramírez; Plamena Gabrovska; Judit Dénes; Karen Stals; Giampaolo Trivellin; Daniel Tilley; Francesco Ferrau; Jane Evanson; Sian Ellard; Ashley B Grossman; Federico Roncaroli; Mónica R Gadelha; Márta Korbonits
Journal:  J Clin Endocrinol Metab       Date:  2015-09       Impact factor: 5.958

8.  Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation‒Positive Child.

Authors:  Pinaki Dutta; Kavita S Reddy; Ashutosh Rai; Anil K Madugundu; Hitendra S Solanki; Anil Bhansali; Bishan D Radotra; Narendra Kumar; David Collier; Donato Iacovazzo; Prakamya Gupta; Remya Raja; Harsha Gowda; Akhilesh Pandey; Jagtar Singh Devgun; Márta Korbonits
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

9.  Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors.

Authors:  Pedro Marques; Francisca Caimari; Laura C Hernández-Ramírez; David Collier; Donato Iacovazzo; Amy Ronaldson; Kesson Magid; Chung Thong Lim; Karen Stals; Sian Ellard; Ashley B Grossman; Márta Korbonits
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 6.134

10.  Increased Population Risk of AIP-Related Acromegaly and Gigantism in Ireland.

Authors:  Serban Radian; Yoan Diekmann; Plamena Gabrovska; Brendan Holland; Lisa Bradley; Helen Wallace; Karen Stals; Anna-Marie Bussell; Karen McGurren; Martin Cuesta; Anthony W Ryan; Maria Herincs; Laura C Hernández-Ramírez; Aidan Holland; Jade Samuels; Elena Daniela Aflorei; Sayka Barry; Judit Dénes; Ida Pernicova; Craig E Stiles; Giampaolo Trivellin; Ronan McCloskey; Michal Ajzensztejn; Noina Abid; Scott A Akker; Moises Mercado; Mark Cohen; Rajesh V Thakker; Stephanie Baldeweg; Ariel Barkan; Madalina Musat; Miles Levy; Stephen M Orme; Martina Unterländer; Joachim Burger; Ajith V Kumar; Sian Ellard; Joseph McPartlin; Ross McManus; Gerard J Linden; Brew Atkinson; David J Balding; Amar Agha; Chris J Thompson; Steven J Hunter; Mark G Thomas; Patrick J Morrison; Márta Korbonits
Journal:  Hum Mutat       Date:  2016-10-04       Impact factor: 4.700

View more
  3 in total

Review 1.  Aggressive prolactinoma (Review).

Authors:  Ana Valea; Florica Sandru; Aida Petca; Mihai Cristian Dumitrascu; Mara Carsote; Razvan-Cosmin Petca; Adina Ghemigian
Journal:  Exp Ther Med       Date:  2021-11-24       Impact factor: 2.447

2.  RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas.

Authors:  Miguel Chenlo; Fernando Oroz-Gonjar; Márta Korbonits; Clara V Alvarez; Angela R Garcia-Rendueles; Antonia Solomou; Anisha Mistry; Sayka Barry; Carles Gaston-Massuet; Montserrat Garcia-Lavandeira; Sihara Perez-Romero; Maria Suarez-Fariña; Alberto Pradilla-Dieste; Carlos Dieguez; Patrick Mehlen
Journal:  Oncogene       Date:  2021-09-29       Impact factor: 9.867

Review 3.  Genetics of Acromegaly and Gigantism.

Authors:  Anna Bogusławska; Márta Korbonits
Journal:  J Clin Med       Date:  2021-03-29       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.